Relationship between the intratumor pharmacokinetics and antitumor effect of the payload eribulin in the novel antibody-drug conjugate MORAb-202

被引：0
|
作者：
Koganemaru, S. [1 ]
Fuchigami, H. [2 ]
Tsugawa, H. [2 ]
Kuboki, Y. [1 ]
Furuuchi, K. [3 ]
Uenaka, T. [3 ]
Doi, T. [1 ]
Yasunaga, M. [2 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Expt Therapeut, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[3] Eisai Inc, Epochal Precis Anticanc Therapeut EPAT, Exton, PA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
242
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [31] Evaluation of Quantitative Relationship Between Target Expression and Antibody-Drug Conjugate Exposure Inside Cancer Cells
    Sharma, Sharad
    Li, Zhe
    Bussing, David
    Shah, Dhaval K.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (05) : 368 - 377
  • [32] Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived Xenografts
    Abu-Yousif, Adnan O.
    Cvet, Donna
    Gallery, Melissa
    Bannerman, Bret M.
    Ganno, Michelle L.
    Smith, Michael D.
    Lai, Katharine C.
    Keating, Thomas A.
    Stringer, Bradley
    Kamali, Afrand
    Eng, Kurt
    Koseoglu, Secil
    Zhu, Andy
    Xia, Cindy Q.
    Landen, Melissa Saylor
    Borland, Maria
    Robertson, Robbie
    Bolleddula, Jayaprakasam
    Qian, Mark G.
    Fretland, Jennifer
    Veiby, O. Petter
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2079 - 2088
  • [33] Pharmacokinetic-Pharmacodynamic Modeling of the Antitumor Effects of SGN-CD19A, a Novel Antibody-Drug Conjugate, in Mice
    Zhao, Baiteng
    Stevison, Faith
    Law, Che-Leung
    Han, Tae H.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S17 - S18
  • [34] YH013, a novel EGFR x MET bispecific antibody-drug conjugate, exhibits potent antitumor efficacy
    Han, Yanfei
    Shang, Chengzhang
    Li, Zhuon
    Han, Zhenyan
    Li, Jun
    Cui, Zixu
    An, Gao
    Hao, Wanjun
    Liu, Yujie
    Li, Hao
    Liu, Baihong
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    Shen, Yuelei
    CANCER RESEARCH, 2023, 83 (07)
  • [35] A novel dual drug antibody-drug conjugate targeting hTrop2 has synergetic antitumor activity in solid tumor models
    Zhu, Jie
    Zhao, Xiaobei
    Li, Eileen
    Xu, Hong
    Nie, Lei
    Chen, Gang
    Wang, Haibing
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
    Liu, Hongfu
    Zhou, Dongdong
    Liu, Dongqin
    Xu, Xi
    Zhang, Kai
    Hu, Ruxia
    Xiong, Peng
    Wang, Changxin
    Zeng, Xiangfu
    Wang, Liefeng
    Zhang, Shuyong
    CELL DEATH & DISEASE, 2024, 15 (03)
  • [37] Preclinical evaluation of IM-1021, a ROR1-targeted antibody-drug conjugate with a novel topoisomerase I linker payload
    Lawrence, R.
    Arthur, W.
    Gavai, A.
    Han, X.
    Fischer, K.
    Bunker, K.
    Higgins, J.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S69 - S70
  • [38] Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
    Hongfu Liu
    Dongdong Zhou
    Dongqin Liu
    Xi Xu
    Kai Zhang
    Ruxia Hu
    Peng Xiong
    Changxin Wang
    Xiangfu Zeng
    Liefeng Wang
    Shuyong Zhang
    Cell Death & Disease, 15
  • [39] In vitro and in vivo activity of a novel c-Met-targeting antibody-drug conjugate using a DNA-alkylating, indolinobenzodiazepine payload
    Lai, Katharine C.
    Muvaffak, Asli
    Li, Min
    Themeles, Marian
    Sikka, Surina
    Donahue, Kerry
    Hicks, Stuart W.
    Romanelli, Angela
    Chittenden, Thomas
    CANCER RESEARCH, 2017, 77
  • [40] Antitumor effect of humanized anti-tissue factor antibody-drug conjugate in a model of peritoneal disseminated pancreatic cancer
    Tsumura, Ryo
    Anzai, Takahiro
    Manabe, Shino
    Takashima, Hiroki
    Koga, Yoshikatsu
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    ONCOLOGY REPORTS, 2021, 45 (01) : 329 - 336
12345